Monitoring treatment response with disease-modifying therapies (DMTs) and identifying when to change treatment strategies for multiple sclerosis (MS) is a complex process that is crucial to delivering optimized care. Join us for this 45-minute video featuring MS experts to discuss evidence-based approaches for monitoring therapeutic response and sequencing DMTs. Discussion items in the video include: reviewing evidence-based guidance on identifying suboptimal treatment response and methods for monitoring therapy exploring treatment pathways for patients with inadequate treatment response discussing patient cases from the project ECHO initiative and their application into practice. Participants will also have access to a downloadable pocket guide that will highlight key items for treatment selection, including prognostic factors, monitoring treatment response, and patient individualization.
- Provider:PRIME Education, Inc. (PRIME®)
- Activity Link: https://primeinc.org/online/monitoring-therapy-response-timely-appropriate-decisions-switch-escalate-dmts
- Start Date: 2024-08-28 05:00:00
- End Date: 2024-08-28 05:00:00
- Credit Details: AAPA Category 1 Credit™️: 0.75 hours
AMA PRA Category 1 Credit™️: 0.75 hours
Nursing: 0.75 hours
Pharmacy: 0.75 hours - Commercial Support: Source: Bristol-Myers Squibb Company - Amount: 1666.67 - Is Kind Support: False Source: Genentech (Any division) - Amount: 28250.0 - Is Kind Support: False Source: Novartis Corporation Pharmaceuticals - Amount: 24916.67 - Is Kind Support: False Source: Viatris - Amount: 28250.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner/Team Competence, Learner/Team Performance
- Provider Ship: Directly Provided
- Registration: Open to all